Empreu aquest identificador per citar o enllaçar aquest ítem: http://hdl.handle.net/10609/146568
Títol: HPV prevention and control - The way forward
Autoria: Vorsters, Alex  
BOSCH JOSÉ, FRANCESC XAVIER  
Poljak, Mario  
Waheed, Dur-e-Nayab  
Stanley, Margaret
Garland, Suzanne M.
Altres: HPV Prevention and Control Board and the International Papillomavirus Society (IPVS)
University of Antwerp
Institut Català d'Oncologia
University of Ljubljana
University of Cambridge
University of Melbourne
Universitat Oberta de Catalunya
Citació: Vorsters, A., Bosch, F. X., Poljak, M., Waheed, D.-N., Stanley, M., & Garland, S. M. (2022). HPV prevention and control - The way forward. Preventive Medicine, 156, 106960. doi: 10.1016/j.ypmed.2022.106960
Resum: The global confrontation with COVID-19 has not only diverted current healthcare resources to deal with the infection but has also resulted in increased resources in the areas of testing and screening, as well as educating most of the global public of the benefits of vaccination. When the COVID-19 pandemic eventually recedes, the opportunity must not be missed to ensure that these newly created resources are maintained and redeployed for use in testing and immunisation against other vaccine-preventable infectious diseases. A notable example is infection by human papillomavirus (HPV), the commonest sexually transmitted human virus and the leading cause of a variety of cancers in both men and women, such as cervical, head and neck, anal, vaginal, vulvar and penile cancers. The most important is cervical cancer, the objective of the global elimination goals targeting the vaccination of young female and male adolescents, screening all women and treatment of all infected women. As the campaigns to control SARS-CoV-2, the eradication of HPV-induced cancers also relies on effective prevention and control programs. The lessons learned and the technical, logistical and human resources which have been established to combat COVID-19 by vaccination and testing must be applied to the eradication of other infections which affect the global population. This commentary summarizes the opportunities that the COVID-19 pandemic has created for HPV prevention and control, lists the already available tools for HPV control, and emphasizes the potential public health threats amidst the ongoing COVID-19 pandemic.
Paraules clau: VPH
prevenció i control
càncer de coll uterí
eliminació de la pandèmia COVID-19
cribratge
vacunació
tractament
DOI: http://doi.org/10.1016/j.ypmed.2022.106960
Tipus de document: info:eu-repo/semantics/article
Versió del document: info:eu-repo/semantics/acceptedVersion
Data de publicació: 20-gen-2022
Llicència de publicació: https://creativecommons.org/licenses/by-nc-nd/4.0  
Apareix a les col·leccions:Articles
Articles cientÍfics

Arxius per aquest ítem:
Arxiu Descripció MidaFormat 
bosch_PMC_HPV.pdf411,69 kBAdobe PDFThumbnail
Veure/Obrir
Comparteix:
Exporta:
Consulta les estadístiques

Aquest ítem està subjecte a una llicència de Creative Commons Llicència Creative Commons Creative Commons